CLINICAL TRIALS

A 30-day clinical trial was conducted by ABICH LABS in Italy to evaluate the effectiveness of One Truth 818 and its active ingredient TAM-818 (Telomerase Activating Molecule). Involving 100 volunteers aged 36–65, focusing on the product’s ability to deliver visible wrinkle reduction and measurable anti-aging benefits.

Specialized equipment was used, including an in-vivo 3D scanner and a Cutometer, to measure skin surface changes and elasticity.

Participants applied One Truth 818 twice daily to targeted areas such as crow’s feet and the forehead. The trial measured improvements in wrinkle depth, skin roughness, and firmness.

Results showed there is a significant decrease in wrinkle depth and surface roughness in treated areas. Noticeable increase in skin elasticity, confirming the product’s ability to restore resilience. Most importantly,
Volunteers experienced firmer, smoother skin, supporting One Truth 818’s role as a proven anti-aging skincare solution.

ABICH LABS concluded that ONE TRUTH 818 telomerase activating skincare products were shown to be effective in reducing wrinkles and improving skin elasticity and firmness significantly in just 30 days.

Epi-genetic Breakthroughs

Unleashing the Power of the Telomerase Enzyme

Epi-genetic Breakthroughs

Unleashing the Power of the Telomerase Enzyme